ADHD medication associated with reduced rates of suicide, substance misuse, transport accidents and criminality in Swedish study of 148,581 people.
[read the full story...]
How safe is it to treat ADHD in people with schizophrenia spectrum disorders? New long-term data offers pragmatic reassurance, but also some warnings.
[read the full story...]
In her debut blog, Poppy Ellis Logan summarises a longitudinal study which finds rates of ADHD prescription increased in Ireland between 2005 and 2015.
[read the full story...]
David Steele summarises a recent randomised controlled trial, which finds that (in the short-term) Lisdexamfetamine successfully decreased binge-eating behaviour in patients with binge-eating disorder. But can we trust this evidence?
[read the full story...]
